Rare diseases
Investigational molecules
Locations
A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication
BelgiumA study of PF-08634404, ipilimumab, and axitinib in adults with advanced or metastatic kidney cancer
GermanyA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
BelgiumA study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations
DenmarkA study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults
PolandA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
CzechiaA study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years
RomaniaA study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B
FranceA study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases
FranceA study to evaluate the safety and how pivekimab sunirine works in children with relapsed or refractory acute myeloid leukemia
BelgiumA study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer
BelgiumStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
